At GenQual, we develop proprietary companion diagnostics for autoimmune, inflammatory, and cancer therapies.  Our diagnostics are designed to stratify responder cohorts for clinical trials, improve response rates, optimize the regulatory approval pathway, and ultimately, to inform treatment decisions.  GenQual is based in the greater Seattle area and is a privately-held corporation.